Berberine inhibits the development of endometrial cancer through circ_ZNF608/miR-377-3p/COX2 axis

References

• Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366(9484):491–505.
   PubMed Web of Science ®Google Scholar
• Emons G, Fleckenstein G, Hinney B, et al. Hormonal interactions in endometrial cancer. Endocr Relat Cancer. 2000;7(4):227–242.
   PubMedGoogle Scholar
• Mahecha AM, Wang H. The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer. Onco Targets Ther. 2017;10:4617–4624.
   PubMed Web of Science ®Google Scholar
• Mittica G, Ghisoni E, Giannone G, et al. Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity. Oncotarget. 2017;8(52):90532–90544.
   PubMedGoogle Scholar
• Tran AQ, Gehrig P. Recent advances in endometrial cancer. F1000Res. 2017;6:81.
   PubMedGoogle Scholar
• Jin P, Zhang C, Li N. Berberine exhibits antitumor effects in human ovarian cancer cells. Anticancer Agents Med Chem. 2015;15(4):511–516.
   PubMedGoogle Scholar
• Gao Z, Li Q, Wu X, et al. New insights into the mechanisms of Chinese herbal products on diabetes: a focus on the “bacteria-mucosal immunity-inflammation-diabetes” axis. J Immunol Res. 2017;2017:1813086.
   PubMedGoogle Scholar
• Wang Y, Zhang S. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. Biomed Pharmacother. 2018;103:1287–1293.
   PubMed Web of Science ®Google Scholar
• Zhu T, Li LL, Xiao GF, et al. Berberine increases doxorubicin sensitivity by suppressing STAT3 in lung cancer. Am J Chin Med. 2015;43(7):1487–1502.
   PubMedGoogle Scholar
• Kou Y, Li L, Li H, et al. Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARalpha/RARbeta in melanoma cells. Biochem Biophys Res Commun. 2016;479(2):290–296.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Jing Z, Lv J, et al. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo. Biomed Pharmacother. 2017;95:18–24.
   PubMed Web of Science ®Google Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu T, Wang X, et al. Circles reshaping the RNA world: from waste to treasure. Mol Cancer. 2017;16(1):58.
   PubMedGoogle Scholar
• Hansen TB, Kjems J, Damgaard CK. Circular RNA and miR-7 in cancer. Cancer Res. 2013;73(18):5609–5612.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yin L, Sun X. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway. J Exp Clin Cancer Res. 2020;39(1):169.
   PubMed Web of Science ®Google Scholar
• Zong ZH, Liu Y, Chen S, et al. Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway. J Cell Mol Med. 2020;24(7):4127–4135.
   PubMed Web of Science ®Google Scholar
• Baez-Vega PM, Echevarria Vargas IM, Valiyeva F, et al. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells. Oncotarget. 2016;7(24):36321–36337.
   PubMedGoogle Scholar
• Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics. 2010;11(7):537–561.
   PubMed Web of Science ®Google Scholar
• Chen X, Tang JP, Zhang H. L. miR-135a acts as a tumor suppressor by targeting ASPH in endometrial cancer. Int J Clin Exp Pathol. 2019;12:3384–3389.
   PubMedGoogle Scholar
• Fridrichova I, Kalinkova L, Karhanek M, et al. miR-497-5p decreased expression associated with high-risk endometrial cancer. IJMS. 2020;22(1):127.
   Google Scholar
• He Y, Ma H, Wang J, et al. miR-20a-5p inhibits endometrial cancer progression by targeting janus kinase 1. Oncol Lett. 2021;21(5):427.
   PubMedGoogle Scholar
• Lu Z, Xu Y, Yao Y, et al. miR-205-5p contributes to paclitaxel resistance and progression of endometrial cancer by downregulating FOXO1. Oncol Res. 2019.
   Google Scholar
• Sun X, Hou L, Qiu C, et al. MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer. Cell Mol Biol Lett. 2021;26(1):20.
   PubMedGoogle Scholar
• Wang KH, Kao AP, Chang CC, et al. Bisphenol A-induced epithelial to mesenchymal transition is mediated by cyclooxygenase-2 up-regulation in human endometrial carcinoma cells. Reprod Toxicol. 2015;58:229–233.
   PubMedGoogle Scholar
• Ohno S, Ohno Y, Suzuki N, et al. Multiple roles of cyclooxygenase-2 in endometrial cancer. Anticancer Res. 2005;25(6A):3679–3687.
   PubMedGoogle Scholar
• Liu K, Mou Y, Shi X, et al. Circular RNA 100146 promotes colorectal cancer progression by the microRNA 149/HMGA2 axis. Mol Cell Biol. 2021;41(2):e00445–20.
   PubMedGoogle Scholar
• Viswanathan SR, Powers JT, Einhorn W, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009;41(7):843–848.
   PubMed Web of Science ®Google Scholar
• Ma W, Zhu M, Zhang D, et al. Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2. Phytomedicine. 2017;25:45–51.
   PubMed Web of Science ®Google Scholar
• Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther. 2006;5(2):296–308.
   PubMedGoogle Scholar
• Wang M, Sun L, Wang L, et al. Effects of berberine on circular RNA expression profiles in human gastric cancer cells. Evid Based Complement Alternat Med. 2021;2021:6688629.
   PubMedGoogle Scholar
• Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–226.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Rahman MA, Chen ZG, et al. Multiple biological functions of Twist1 in various cancers. Oncotarget. 2017;8(12):20380–20393.
   PubMedGoogle Scholar
• Arnaiz E, Sole C, Manterola L, et al. CircRNAs and cancer: biomarkers and master regulators. Semin Cancer Biol. 2019;58:90–99.
   PubMed Web of Science ®Google Scholar